Literature DB >> 33318294

Identification of key modules and genes associated with breast cancer prognosis using WGCNA and ceRNA network analysis.

Xin Yin1, Pei Wang1, Tianshu Yang1, Gen Li1, Xu Teng1, Wei Huang1, Hefen Yu1.   

Abstract

Breast cancer is one of the leading causes of cancer-associated mortality in women worldwide and has become a major public health problem. Although the definitive cause of breast cancer is not known, many genes sensitive to breast cancer have been detected using advanced technologies. Our study identified 3301 differentially expressed lncRNAs and mRNAs between tumor and normal samples from The Cancer Genome Atlas database. Based on the gene expression analysis and clinical traits as well as weighted gene co-expression network analysis, the co-expression Brown module was found to be key for breast cancer prognosis. A total of 453 genes in the Brown module were used for functional enrichment, protein-protein interaction analysis, lncRNA-miRNA-mRNA ceRNA network, and lncRNA-RNA binding protein-mRNA network construction. GRM4, SSTR2, PARD6B, PRR15, COX6C, and lncRNA DSCAM-AS1 were the hub genes according to protein-protein interaction, lncRNA-miRNA-mRNA and lncRNA-RNA binding protein-mRNA network. Their high expression was found to be correlated with breast cancer development, according to multiple databases. In conclusion, this study provides a framework of the co-expression gene modules of breast cancer and identifies several important biomarkers in breast cancer development and prognosis.

Entities:  

Keywords:  PPI network; WGCNA; breast cancer; differential expression analysis; lncRNA

Mesh:

Substances:

Year:  2020        PMID: 33318294      PMCID: PMC7880379          DOI: 10.18632/aging.202285

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  57 in total

Review 1.  RNA sequencing: advances, challenges and opportunities.

Authors:  Fatih Ozsolak; Patrice M Milos
Journal:  Nat Rev Genet       Date:  2010-12-30       Impact factor: 53.242

Review 2.  Comparison of Methods for Differential Co-expression Analysis for Disease Biomarker Prediction.

Authors:  Tulika Kakati; Dhruba K Bhattacharyya; Pankaj Barah; Jugal K Kalita
Journal:  Comput Biol Med       Date:  2019-08-10       Impact factor: 4.589

3.  Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas.

Authors:  Luisa Iacovelli; Antonietta Arcella; Giuseppe Battaglia; Simonetta Pazzaglia; Eleonora Aronica; Paola Spinsanti; Alessandra Caruso; Enrico De Smaele; Anna Saran; Alberto Gulino; Mara D'Onofrio; Felice Giangaspero; Ferdinando Nicoletti
Journal:  J Neurosci       Date:  2006-08-09       Impact factor: 6.167

4.  Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway.

Authors:  Corinne Bousquet; Julie Guillermet-Guibert; Nathalie Saint-Laurent; Elodie Archer-Lahlou; Frédéric Lopez; Marjorie Fanjul; Audrey Ferrand; Daniel Fourmy; Carole Pichereaux; Bernard Monsarrat; Lucien Pradayrol; Jean-Pierre Estève; Christiane Susini
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

5.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

Review 6.  The long non-coding RNA H19: an active player with multiple facets to sustain the hallmarks of cancer.

Authors:  Clément Lecerf; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Cell Mol Life Sci       Date:  2019-07-23       Impact factor: 9.261

7.  The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells.

Authors:  Yong He; Xiao-Mei Yuan; Ping Lei; Sha Wu; Wei Xing; Xiao-Li Lan; Hui-Fen Zhu; Tao Huang; Guo-Bing Wang; Rui An; Yong-Xue Zhang; Guan-Xin Shen
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

8.  PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer.

Authors:  Heather E Cunliffe; Yuan Jiang; Kimberly M Fornace; Fan Yang; Paul S Meltzer
Journal:  Am J Cancer Res       Date:  2012-08-20       Impact factor: 6.166

9.  Identification of an eight-lncRNA prognostic model for breast cancer using WGCNA network analysis and a Cox‑proportional hazards model based on L1-penalized estimation.

Authors:  Zhenbin Liu; Menghu Li; Qi Hua; Yanfang Li; Gang Wang
Journal:  Int J Mol Med       Date:  2019-08-06       Impact factor: 4.101

Review 10.  The network of non-coding RNAs and their molecular targets in breast cancer.

Authors:  Francesca Crudele; Nicoletta Bianchi; Eva Reali; Marco Galasso; Chiara Agnoletto; Stefano Volinia
Journal:  Mol Cancer       Date:  2020-03-18       Impact factor: 27.401

View more
  16 in total

1.  An Integrated Immune-Related Bioinformatics Analysis in Glioma: Prognostic Signature's Identification and Multi-Omics Mechanisms' Exploration.

Authors:  Xin Fan; Lingling Zhang; Junwen Huang; Yun Zhong; Yanting Fan; Tong Zhou; Min Lu
Journal:  Front Genet       Date:  2022-05-03       Impact factor: 4.772

2.  Construction of a ceRNA immunoregulatory network related to the development of vascular dementia through a weighted gene coexpression network analysis.

Authors:  Hongshuo Shi; Fengshan Sun; Tiantian Yang; Min Peng; Min Wang; Yiwen Zhang; Yao Wang; Chengda Dong; Zhaojun Yan; Guomin Si; Wenbo Wang; Yujie Li
Journal:  Ann Transl Med       Date:  2021-05

3.  PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer.

Authors:  Jing Li; Wei-Min Kong
Journal:  J Immunol Res       Date:  2022-04-20       Impact factor: 4.493

4.  Identifying critical protein-coding genes and long non-coding RNAs in non-functioning pituitary adenoma recurrence.

Authors:  Jing Guo; Qiuyue Fang; Yulou Liu; Weiyan Xie; Yazhuo Zhang; Chuzhong Li
Journal:  Oncol Lett       Date:  2021-02-08       Impact factor: 2.967

5.  Identification of Key Transcription Factors and Immune Infiltration Patterns Associated With Breast Cancer Prognosis Using WGCNA and Cox Regression Analysis.

Authors:  Xin Yin; Jiaxiang Liu; Xin Wang; Tianshu Yang; Gen Li; Yaxin Shang; Xu Teng; Hefen Yu; Shuang Wang; Wei Huang
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

6.  Somatostatin Receptor 2: A Potential Predictive Biomarker for Immune Checkpoint Inhibitor Treatment.

Authors:  Aoyun Wang; Yixiao Yuan; Han Chu; Yixing Gao; Zheng Jin; Qingzhu Jia; Bo Zhu
Journal:  Pathol Oncol Res       Date:  2022-02-21       Impact factor: 3.201

7.  Evaluating the cytotoxicity and pathogenicity of multi-walled carbon nanotube through weighted gene co-expression network analysis: a nanotoxicogenomics study.

Authors:  Shameran Jamal Salih; Mohadeseh Zarei Ghobadi
Journal:  BMC Genom Data       Date:  2022-02-17

8.  Integrated Analysis of miR-7-5p-Related ceRNA Network Reveals Potential Biomarkers for the Clinical Outcome of Gastric Cancer.

Authors:  Meng-Yang Shi; Yan-Fei Mu; Neng Shen
Journal:  J Oncol       Date:  2022-02-14       Impact factor: 4.501

9.  Identification of Potential Biomarkers for Progression and Prognosis of Bladder Cancer by Comprehensive Bioinformatics Analysis.

Authors:  Zhiyong Tan; Shi Fu; Runlin Feng; Yinglong Huang; Ning Li; Haifeng Wang; Jiansong Wang
Journal:  J Oncol       Date:  2022-04-19       Impact factor: 4.501

10.  Identification of Hub Diagnostic Biomarkers and Candidate Therapeutic Drugs in Heart Failure.

Authors:  Yang Guo; Bobin Ning; Qunhui Zhang; Jing Ma; Linlin Zhao; QiQin Lu; Dejun Zhang
Journal:  Int J Gen Med       Date:  2022-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.